InsidersTradesSigma
Follow the ARC share price and the full insider trade history of the company, a listed issuer based in Australia. Shares are quoted on the AU market, under the supervision of ASX. Operating in the Health Care sector, ARC has logged 6 reports. Market capitalisation: €5.2m. The latest transaction was filed on 18 June 2026 (Purchase). Among the most active insiders: Scott Beeton. All data is accessible without an account.
6
Insider Decl.
n/a
Thresholds
€60,830
2 ops.
Buy Volume
n/a
n/a
Sell Volume
32Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 18 June 2026
Declarations6 total
29,510 shares0.0000% mcap100.0% of flowShareASXASX:2924-03101842-2A1678187
ShareASXASX:2924-03101143-2A1677850
1.16% mcap100.0% of flowShareASXASX:2924-03100774-2A1677678
6 of 6 declarations
About ARC
ARC is a healthcare and pharmaceutical company listed on the XASX market. It focuses on developing innovative solutions to enhance healthcare.